-
ALSO READ
Rupee falls by 11 paise to 72.83 against US dollar
Rupee surges 18 paise to 72.42 against the US dollar in early trade
Rupee rises 13 paise to settle at 73.29 on weaker US dollar today
Rupee strengthens by 8 paise to 72.54 against US dollar in early trade
Rupee gains for 2nd straight session on positive equities, rises by 7 paise
-
Extending losses for the second straight session, the rupee on Tuesday fell by another 28 paise to end at 72.90 against the US dollar in line with muted domestic equities.
The rupee opened on a marginally positive note at 72.57 per dollar as against its previous close of 72.62 at the interbank foreign exchange market. It hovered in the range of 72.54 to 72.94 per dollar during the day before ending at 72.90.
The domestic currency has lost 45 paise in the two trading sessions to Tuesday.
Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, rose 0.01 per cent to 89.83.
On the domestic equity market front, the BSE Sensex ended 2.56 points lower at 51,934.88, while the broader NSE Nifty fell 7.95 points or 0.05 per cent to close at 15,574.85.
Brent crude futures, the global oil benchmark, rose 2.02 per cent to USD 70.72 per barrel.
Foreign institutional investors were net buyers in the capital market on Monday as they purchased shares worth Rs 2,412.39 crore, as per exchange data.
Sophie Altermatt, Economist, Julius Baer, said, "On the currency front, the shock caused by the second wave appears to have been well digested. The INR has fully recovered from its April losses in May as risk sentiment rose on the back of declining new daily COVID-19 cases."
"The path ahead might be more bumpy as uncertainties around the development of the pandemic situation and the economic recovery could reverse some of the INR strength and keep volatility elevated in the near term. We maintain a Neutral view on the INR."
Meanwhile, India reported 1,27,510 fresh COVID-19 cases, the lowest in 54 days, while the daily positivity rate dropped to 6.62 per cent, according to the Union Health Ministry data updated on Tuesday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU